Skip to search formSkip to main contentSkip to account menu

N 696

Known as: N-696 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
  • R. Mayer
  • Journal of clinical oncology : official journal…
  • 2012
  • Corpus ID: 46372153
The ability of adjuvant fluorouracil-based therapy to significantly enhance survival in patients with stage III colon cancer was… 
1991
1991
Vasorelaxant and hypotensive effects of tilisolol hydrochloride (N-696) in isolated rat thoracic aorta and pithed rats were… 
1985
1985
To characterize the alpha 1-adrenoceptors in the dog aorta and the rat brain and to assess the antagonistic potencies of various… 
1985
1985
Binding characteristics of the β-antagonists and agonists with the β-adrenoceptors were investigated in [3H] dihydroalprenolol… 
1985
1985
4-[3-(tert-Butylamino)-2-hydroxypropoxy]-N-methylisocarbostyril hydrochloride (N-696) is a new beta-adrenoceptor blocking drug… 
1984
1984
To characterize the pharmacological profile of a new beta-adrenoceptor blocker, 4-[3-(tert-butylamino)-2-hydroxypropoxy]-N… 
1984
1984
To assess the beta-blocking potencies of three newly synthesized beta-blockers, i.e., S-596: dl-2-(3'-t-butylamino-2… 
1984
1984
We evaluated antiarrhythmic effects of N-696 using canine digitalis ventricular arrhythmia models and electrophysiological… 
1983
1983
Summary We determined the minimum effective plasma concentrations of several antiarrhythmic agents against canine halothane… 
Highly Cited
1982
Highly Cited
1982
Seven drugs were tested for their antiarrhythmic effects on ventricular arrhythmias 24 and 48 hr after two-stage coronary…